Abstract
DNA interstrand crosslinks (ICLs) are critical lesions for the mammalian cell since they affect both DNA strands and block transcription and replication. The repair of ICLs in the mammalian cell involves components of different repair pathways such as nucleotide-excision repair and the double-strand break/homologous recombination repair pathways. However, the mechanistic details of mammalian ICL repair have not been fully delineated. We describe here the complete coding sequence and the genomic organization of hSNM1B, one of at least three human homologs of the Saccharomyces cerevisiae PSO2 gene. Depletion of hSNM1B by RNA interference rendered cells hypersensitive to ICL-inducing agents. This requirement for hSNM1B in the cellular response to ICL has been hypothesized before but never experimentally verified. In addition, siRNA knockdown of hSNM1B rendered cells sensitive to ionizing radiation, suggesting the possibility of hSNM1B involvement in homologous recombination repair of double-strand breaks arising as intermediates of ICL repair. Monoubiquitination of FANCD2, a key step in the FANC/BRCA pathway, is not affected in hSNM1B-depleted HeLa cells, indicating that hSNM1B is probably not a part of the Fanconi anemia core complex. Nonetheless, similarities in the phenotype of hSNM1B-depleted cells and cultured cells from patients suffering from Fanconi anemia make hSNM1B a candidate for one of the as yet unidentified Fanconi anemia genes not involved in monoubiquitination of FANCD2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brendel M, Bonatto D, Strauss M, Revers LF, Pungartnik C, Saffi J and Henriques JAP . (2003). Mutat. Res. Rev. Mutat. Res., 544, 179–193.
Bruun D, Folias A, Akkari Y, Cox Y, Olson S and Moses R . (2003). DNA Repair, 2, 1007–1013.
Caldecott K and Jeggo P . (1991). Mutat. Res., 255, 111–121.
Callebaut I, Moshous D, Mornon JP and De Villartay JP . (2002). Nucleic Acids Res., 30, 3592–3601.
Carreau M, Alon N, Bosnoyan-Collins L, Joenje H and Buchwald M . (1999). Mutat. Res. DNA Repair, 435, 103–109.
Cassier C, Chanet R, Henriques JA and Moustacchi E . (1980). Genetics, 96, 841–857.
Cassier-Chauvat C and Moustacchi E . (1988). Curr. Genet., 13, 37–40.
Cerosaletti KM and Concannon P . (2003). J. Biol. Chem., 278, 21944–21951.
D'Andrea AD and Grompe M . (2003). Nat. Rev. Cancer, 3, 23–34.
De Silva IU, McHugh PJ, Clingen PH and Hartley JA . (2000). Mol. Cell. Biol., 20, 7980–7990.
de Winter JP, Leveille F, van Berkel CGM, Rooimans MA, van der Weel L, Steltenpool J, Demuth I, Morgan NV, Alon N, Bosnoyan-Collins L, Lightfoot J, Leegwater PA, Waisfisz Q, Komatsu K, Arwert F, Pronk JC, Mathew CG, Digweed M, Buchwald M and Joenje H . (2000a). Am. J. Hum. Genet., 67, 1306–1308.
de Winter JP, Rooimans MA, van der Weel L, van Berkel CGM, Alon N, Bosnoyan-Collins L, de Groot J, Zhi Y, Waisfisz Q, Pronk JC, Arwert F, Mathew CG, Scheper RJ, Hoatlin ME, Buchwald M and Joenje H . (2000b). Nat. Genet., 24, 15–16.
de Winter JP, Waisfisz Q, Rooimans MA, van Berkel CGM, Bosnoyan-Collins L, Alon N, Carreau M, Bender O, Demuth I, Schindler D, Pronk JC, Arwert F, Hoehn H, Digweed M, Buchwald M and Joenje H . (1998). Nat. Genet., 20, 281–283.
Demuth I and Digweed M . (1998). Mutat. Res. DNA Repair, 409, 11–16.
Digweed M, Demuth I, Rothe S, Scholz R, Jordan A, Grotzinger C, Schindler D, Grompe M and Sperling K . (2002). Oncogene, 21, 4873–4878.
DiTullio RA, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J and Halazonetis TD . (2002). Nat. Cell Biol., 4, 998–1002.
Dronkert MLG, de Wit J, Boeve M, Vasconcelos ML, van Steeg H, Tan TLR, Hoeijmakers JHJ and Kanaar R . (2000). Mol. Cell. Biol., 20, 4553–4561.
Elbashir SM, Harborth J, Weber K and Tuschl T . (2002). Methods, 26, 199–213.
Essers J, Hendriks RW, Swagemakers SMA, Troelstra C, deWit J, Bootsma D, Hoeijmakers JHJ and Kanaar R . (1997). Cell, 89, 195–204.
Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M and D'Andrea AD . (2001). Mol. Cell, 7, 249–262.
Gatti RA . (2001). Acta Oncol., 40, 702–711.
Henriques JAP and Moustacchi E . (1980). Genetics, 95, 273–288.
Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA and D'Andrea AD . (2002). Science, 297, 606–609.
Jachymczyk WJ, Vonborstel RC, Mowat MRA and Hastings PJ . (1981). Mol. Gen. Genet., 182, 196–205.
Jenny A, Minvielle-Sebastia L, Preker PJ and Keller W . (1996). Science, 274, 1514–1517.
Joenje H and Patel KJ . (2001). Nat. Rev. Genet., 2, 446–457.
Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, Hoatlin ME, Waisfisz Q, Arwert F, de Winter JP and Joenje H . (2003). Blood, 103, 2498–2503.
Lo Len Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, vanBerkel CGM, Strunk MHP, Gille JJP, Pals G, Kruyt FAE, Pronk JC, Arwert F, Buchwald M and Joenje H . (1996). Nat. Genet., 14, 488–488.
Ma YM, Pannicke U, Schwarz K and Lieber MR . (2002). Cell, 108, 781–794.
Magana-Schwencke N, Henriques JAP, Chanet R and Moustacchi E . (1982). Proc. Natl. Acad. Sci. USA Biol. Sci., 79, 1722–1726.
McHugh PJ, Sones WR and Hartley JA . (2000). Mol. Cell. Biol., 20, 3425–3433.
McHugh PJ, Spanswick VJ and Hartley JA . (2001). Lancet Oncol., 2, 483–490.
Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan ZJ, Ling C, Bishop CE, Hoatlin ME, Joenje H and Wang WD . (2003). Nat. Genet., 35, 165–170.
Moshous D, Callebaut I, De Chasseval R, Corneo B, Cavazzana-Calvo M, le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A and De Villartay JP . (2001). Cell, 105, 177–186.
Moynahan ME, Cui TY and Jasin M . (2001). Cancer Res., 61, 4842–4850.
Nagase T, Miyajima N, Tanaka A, Sazuka T, Seki N, Sato S, Tabata S, Ishikawa K, Kawarabayasi Y and Kotani H . (1995). DNA Res., 2, 37–43.
Patel KJ, Yu VPCC, Lee HS, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BAJ and Venkitaraman AR . (1998). Mol. Cell, 1, 347–357.
Richie CT, Peterson C, Lu T, Hittelman WN, Carpenter PB and Legerski RJ . (2002). Mol. Cell. Biol., 22, 8635–8647.
Richter D, Niegemann E and Brendel M . (1992). Mol. Gen. Genet., 231, 194–200.
Rooney S, Sekiguchi J, Zhu CM, Cheng HL, Manis J, Whitlow S, DeVido J, Foy D, Chaudhuri J, Lombard D and Alt FW . (2002). Mol. Cell, 10, 1379–1390.
Rothfuss A and Grompe M . (2004). Mol. Cell Biol., 24, 123–124.
Strathdee CA, Gavish H, Shannon WR and Buchwald M . (1992). Nature, 356, 763–767.
Tavtigian SV, Simard J, Teng D H F, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J and Cannon-Albright LA . (2001). Nat. Genet., 27, 172–180.
The Fanconi anaemia/breast cancer consortium (1996). Nat. Genet., 14, 324–328.
Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D, Thayer M, Cox B, Olson S, D'Andrea AD, Moses R and Grompe M . (2001). Mol. Cell, 7, 241–248.
Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G and Ashworth A . (1999). Curr. Biol., 9, 1107–1110.
Wilborn F and Brendel M . (1989). Curr. Genet., 16, 331–338.
Acknowledgements
This work was supported by a grant from the National Cancer Institute (CA57569). ID was also supported, in part, by a grant from the Deutsche Forschungsgemeinschaft (Forschungsstipendium). We thank Lemuel Navarro and Anne Morrison for assistance with nucleotide sequencing, Karen Cerosaletti for critical comments on the manuscript, Mary West for assistance in manuscript preparation and Thanos Halazonetis for kindly providing the 53BP1 monoclonal antibody.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demuth, I., Digweed, M. & Concannon, P. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation. Oncogene 23, 8611–8618 (2004). https://doi.org/10.1038/sj.onc.1207895
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207895
Keywords
This article is cited by
-
New mutations in the ATM gene and clinical data of 25 AT patients
neurogenetics (2011)
-
SNMIB/Apollo protects leading-strand telomeres against NHEJ-mediated repair
The EMBO Journal (2010)
-
The MRT-1 nuclease is required for DNA crosslink repair and telomerase activity in vivo in Caenorhabditis elegans
The EMBO Journal (2009)
-
Snm1B/Apollo mediates replication fork collapse and S Phase checkpoint activation in response to DNA interstrand cross-links
Oncogene (2008)
-
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M
Nature Genetics (2005)